Is there a bad guy in this equation? Insurance providers who won't pay for lifesaving drugs, or drug companies charging enormous fees? Economist Jonathan Gruber says no. “We just have to recognize as society that something's changed. We have a new miraculous and expensive mode of treatment, and we, society, need to recognize that we need to act jointly to absorb those costs,” says Gruber. He says absorbing those costs will require government support and negotiated prices. #healthcare #insurance #medicalinnovation #drugpricing #economics